Advertisements

Prednisolone - General Pharma

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Prednisolone - General Pharma

Property Description
Active Ingredient Prednisolone
Form Oral tablet, liquid solution, ophthalmic drops
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Use Treating inflammatory and autoimmune conditions
Origin Synthetic (mimics a natural adrenal hormone)

Prednisolone is a powerful prescription medication and a cornerstone active ingredient classified as an intermediate-acting corticosteroid. This synthetic compound is widely recognized across medical practice for its ability to mimic cortisol, a vital hormone naturally produced by the adrenal glands, which is essential for regulating the body’s metabolism and immune function.

Prednisolone is categorized specifically as a glucocorticoid, a chemical sub-class that supports pharmacological action by directly intervening in the body's inflammatory and immune signaling cascades. Its powerful anti-inflammatory and immunosuppressive properties are clinically recognized for providing rapid relief during acute flare-ups. A typical neutral use scenario involves managing a severe allergic reaction or an acute exacerbation of a chronic inflammatory condition, such as asthma or Crohn's disease.

As an International Nonproprietary Name (INN), Prednisolone is the active substance found in numerous generic and branded formulations globally, including liquid solutions often used for pediatric patients and tablets. Various formulations of prednisolone are approved, establishing its authoritative standing in treating a wide spectrum of disorders.

Advertisements

What side effects are possible with Prednisolone - General Pharma?

Possible side effects and safety information

Prednisolone's safety profile is officially documented across multiple physiological systems, reflecting its potent glucocorticoid activity. The spectrum of potential adverse reactions is closely linked to the dose and duration of systemic exposure, as defined by regulatory labeling.

Key Adverse Reaction Categories

System Organ Class (SOC) Examples of Officially Listed Adverse Reactions
Endocrine and Metabolic Disorders Adrenal suppression, Cushingoid features, weight gain, fluid retention, hyperglycemia.
Musculoskeletal Disorders Osteoporosis, muscle weakness (myopathy), avascular necrosis.
Gastrointestinal Disorders Peptic ulceration, abdominal distension, pancreatitis.
Psychiatric Disorders Mood disturbances (euphoria, depression), insomnia, psychotic manifestations.

Serious adverse reactions documented in regulatory sources include adrenal insufficiency following cessation, avascular necrosis (osteonecrosis), and gastrointestinal perforation.

Time-Related and Population Safety Notes

The official safety information highlights that the most severe and irreversible effects, such as osteoporosis and cataracts, are typically associated with long-term systemic exposure. Conversely, the risk of adrenal insufficiency is a critical safety concern tied to the cessation of prolonged therapy, necessitating a controlled withdrawal process.

Specific safety considerations exist for certain groups: official documents note the potential for growth retardation in pediatric patients with long-term use and an increased risk of effects like hypertension in older adults. Furthermore, the label restricts use in individuals with systemic fungal infections.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The regulatory labeling for Prednisolone outlines specific documented manifestations and required emergency actions related to overdose or high-dose exposure.

Documented Manifestations and Severity

While a single, acute overdose is often described as having low toxicity, official prescribing information notes that excessive exposure may result in an exaggeration of expected corticosteroid effects. Documented manifestations may include convulsions (seizures), nausea and vomiting, insomnia, or agitation. Of particular concern are signs of serious electrolyte imbalance, which may manifest as irregular heart rhythms or hypertension.

Long-term high-dose use is documented to lead to chronic effects known as Cushingoid features, including changes in fat distribution and skin thinning.

Required Emergency Actions

Regulatory authorities mandate that individuals seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if severe, life-threatening symptoms are present, such as trouble breathing, collapse, or a seizure.

No specific antidote is available for Prednisolone overdose. Management is officially described as symptomatic and supportive treatment. In the emergency setting, monitoring procedures listed include checking vital signs and performing an ECG (heart tracing) and blood and urine tests to assess electrolyte balance.

Advertisements

Therapeutic Uses of Prednisolone - General Pharma

Prednisolone may be considered in clinical settings that involve acute or unstable symptom patterns when short-term symptomatic assistance is needed, and is relevant when symptoms that interfere with daily functioning create noticeable physiological strain. The medication is relevant across multiple therapeutic domains.

This medication plays a role in managing conditions characterized by periods of heightened symptoms, including Systemic Lupus Erythematosus, Rheumatoid Arthritis, asthma exacerbations, and inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. It is also relevant for certain allergic reactions and contributes to maintaining a sense of stability during symptomatic phases related to Adrenal Insufficiency.

“Prednisolone is applied in scenarios where additional management of discomfort is required and symptoms that create noticeable functional strain need swift attention.”

Systemic Autoimmune and Rheumatic Flares

It is used in areas where short-term symptom management is appropriate, used when groups of symptoms appear suddenly or fluctuate, such as widespread joint pain, swelling, and stiffness. This generally provides support that helps ease the overall symptom burden, assisting patients with maintaining functional stability.


Quick Fact: Supports Management of Inflammatory Symptoms

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Prednisolone — Official Regulatory Information

The eligibility for prednisolone use is strictly defined by regulatory documents, which establish conditions for absolute non-eligibility and required conditional use.

Absolute Non-Eligibility (Contraindications)

Prednisolone is contraindicated and must not be used by patients with Systemic Fungal Infections or a Known Hypersensitivity to the active substance or any excipients. Use is also prohibited for individuals receiving Live Virus Immunization while on immunosuppressive doses of the medication.


Conditional Eligibility and Restrictions

Use is permitted but requires special caution and close monitoring in specific populations, as outlined in official labeling:

  • Organ Function/Comorbidity: Caution is necessary in patients with hypertension, congestive heart failure, diabetes mellitus, and hepatic or renal impairment. The drug may complicate these existing conditions, necessitating close clinical supervision.
  • Age-Related: While use is established in the pediatric population, long-term pharmacological doses should be avoided due to the risk of growth retardation. In older adults, close supervision is required as common adverse effects may have more serious consequences.
  • Reproductive Status: Use during pregnancy is conditional; it is recommended only when the potential benefit justifies the potential risk to the fetus. During lactation, caution is advised as prednisolone is excreted into human milk in small amounts.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prednisolone interacts with numerous medicinal and non-medicinal products, primarily through enzyme-mediated and pharmacodynamic effects, as documented in official regulatory labeling.

Pharmacokinetic Interactions (Exposure Modification)

Coadministration with CYP3A4 inducers, such as rifampin or phenytoin, may accelerate the metabolism of prednisolone, resulting in a decreased therapeutic effect. Conversely, CYP3A4 inhibitors, including antifungals like ketoconazole, can inhibit its clearance, leading to increased plasma concentrations and potential toxicity. Agents like cholestyramine may also decrease systemic exposure by impairing absorption.

Pharmacodynamic Interactions (Additive Risk)

  • Potassium-Depleting Agents (e.g., certain diuretics): Increased risk of severe hypokalemia.
  • NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): Increased risk of gastrointestinal ulceration and bleeding.
  • Antidiabetic Agents: Prednisolone can antagonize the blood-sugar-lowering effect, requiring monitoring and potential dose adjustment of the antidiabetic medicine.
  • Anticoagulants: The effect of drugs like warfarin may be altered, requiring close monitoring of coagulation parameters.

Formal Restrictions

  • Mifepristone is strictly contraindicated due to its antagonistic properties to glucocorticoids.
  • Live attenuated vaccines are contraindicated during immunosuppressive corticosteroid treatment.

Additionally, specific non-drug products like natural licorice can potentiate corticosteroid effects and should be used cautiously, as noted in official sources.

Advertisements

Mechanism of Action

How Prednisolone Works: Mechanism of Action

Prednisolone functions as a full agonist at the intracellular Glucocorticoid Receptor ( GR), its exclusive target. The activated drug-receptor complex translocates into the nucleus to modulate gene transcription. This involves Transrepression, which suppresses pro-inflammatory transcription factors ( NF-kappa B), and Transactivation, which promotes the synthesis of anti-inflammatory proteins. This core action results in the cessation of pro-inflammatory gene transcription.

This genomic cascade causes a widespread suppression of components within the inflammatory response. The drug's influence leads to a significant reduction in the synthesis of pro-inflammatory cytokines ( IL-1, TNF-alpha). Furthermore, the action of the protein Annexin A1 facilitates the indirect inhibition of the enzyme Phospholipase A2 ( PLA2). Blocking this enzyme halts the formation of prostaglandins and leukotrienes from arachidonic acid, thereby limiting chemical mediators. Additionally, Prednisolone alters the distribution of immune cells, causing lymphocytes, monocytes, and eosinophils to relocate from the bloodstream into other tissues, modulating the cellular phase of the immune response. Because the primary effects rely on gene regulation, the mechanism exhibits a Genomic Lag.

Advertisements

Dosage and Administration Information

Administration Methods

Prednisolone is a corticosteroid that is available in several formulations, including oral tablets, liquid solutions, and topical applications. The method of administration depends entirely on the specific form prescribed and the condition being addressed.

Oral Formulations

Oral prednisolone is typically taken with food or milk. Tablets are designed to be swallowed whole, while liquid forms require the use of a calibrated measuring device to ensure an accurate volume. For certain gastrointestinal conditions, enteric-coated tablets may be used to alter where the medication is absorbed in the digestive tract.

Timing and Routine

Consistency in the timing of administration is a standard practice for maintaining steady levels of the medication in the body. When a single daily dose is required, it is often taken in the morning to align with the body's natural circadian rhythm of cortisol production. In cases where the medication is intended for long-term use, the schedule may involve daily administration or an alternate-day regimen.

Discontinuation Process

The process of stopping prednisolone involves a gradual reduction of the amount taken over a period of time. This transition period allows the adrenal glands to resume their normal production of natural hormones. A sudden cessation of the medication is generally avoided to prevent a disruption in the body's hormonal balance.

Special Considerations for Use

  • Soluble Tablets: Some versions are designed to be dissolved in water before consumption.
  • Storage: Proper storage involves keeping the medication in its original packaging, away from excessive heat and moisture.
  • Monitoring: Regular observation by a healthcare professional is standard practice during the course of use to monitor the body's response to the medication.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prednisolone

Evidence for Use in Inflammatory and Allergic Conditions

Prednisolone was studied for its use in a variety of conditions characterized by fluctuating or episodic manifestations linked to inflammation or allergic reactions. Research has explored outcomes linked to inflammatory or irritative states and outcomes describing episodic or acute changes in symptoms. This research primarily involved clinical trials and observational studies that collected data on patient-reported outcomes describing perceived discomfort.

For these conditions, studies monitored changes during periods of increased symptom activity. The research describes patterns related to how symptoms evolved in the observed populations during defined time intervals.

It is important to remember that results apply only to the populations studied. Research contributes to the broader evidence landscape by helping to contextualize how patients reported their experience, but it does not determine whether an individual will respond similarly.


Evidence for Use in Autoimmune Disorders

The use of prednisolone was evaluated in settings involving conditions associated with acute or disruptive episodes and those marked by functional limitations due to the immune system. Research examined its application in conditions where symptoms may vary in intensity and conditions presenting with cycles of stability and flare-ups. This research focused on the research that examined specific measured changes in the observed conditions.

Studies explored outcomes related to systemic or functional imbalance and outcomes reflecting daily functioning or activity level. The data show patterns related to changes measured during the study period, often involving research focusing on episodes where symptoms become more noticeable. In some study settings, studies contributed to understanding patterns related to changes in these functional outcomes.


Long-term Studies and Follow-up

Research into the use of prednisolone includes studies aiming to explore outcomes over extended periods. This section summarizes what is known and what is still uncertain about long-term outcomes, the durability of response in observed populations, and any extended-duration data.

Data for long-term outcomes remain insufficient because follow-up durations were limited in many of the initial trials. Research that is ongoing often uses observational settings evaluating daily-life functioning, and studies monitor changes over time. Studies exploring short-term symptom changes are more common than those providing comprehensive long-term data.


Evidence in Special Populations

Specific studies have researched and described the use of prednisolone in certain groups of people, including children, older adults, and those with various comorbid conditions. This evidence is gathered to see if there are unique patterns or considerations for these populations.

For some of these groups, the data for certain groups remain insufficient, meaning evidence is limited. For example, sample sizes were modest in some subgroup analyses. Research in these special populations generally monitors outcomes related to physical discomfort and patient-reported outcomes used in research exploring how symptoms change over time.


What is Still Uncertain About Prednisolone - General Pharma

This section synthesizes the areas where the current research landscape has limitations or is still developing. While many studies have been conducted, research gaps exist regarding its use across all potential scenarios.

One key gap is that comparative evidence is lacking in some areas, which makes it challenging to fully assess how observed outcomes relate to other available management approaches. Furthermore, evidence quality varies across studies, which influences the overall certainty of the findings. The primary focus of uncertainty is that long-term effects are not fully established.

Key Studies & References

  1. Systematic review and meta-analysis of glucocorticoid therapy in immune-mediated diseases
  2. Long-term safety of glucocorticoid therapy in chronic inflammatory diseases: A systematic review and meta-analysis
  3. NICE Guideline NG135: Management of Chronic Inflammatory Conditions (referencing systemic corticosteroid use)
  4. Glucocorticoid treatment during pregnancy: A systematic review of developmental outcomes
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Prednisolone - General Pharma (FAQ)


Q: How quickly does prednisolone start to work for inflammation?

Prednisolone is generally described as a medication that acts quickly. Official information indicates that the anti-inflammatory effects potentially beginning within a few hours to days after the first dose is taken, depending on the condition being treated and the dosage form used.


Q: What is the general difference between prednisolone and prednisone?

Prednisone is a prodrug, which means it is an inactive form of the medication. It requires conversion by enzymes in the liver to become the active drug, which is prednisolone. Due to this metabolic difference, prednisolone is sometimes preferred for individuals who may have severe liver function issues.


Q: Can people with a history of stomach ulcers use prednisolone?

According to official product information, corticosteroids should be used with special caution in patients with an active or latent peptic ulcer, or a history of peptic ulcer disease. This is because their use may increase the risk of serious gastrointestinal complications, and close monitoring may be recommended by a healthcare professional.


Q: Do studies show long-term use of prednisolone can affect bone density?

Official safety documents list osteoporosis (decreased bone density) as a potential long-term adverse reaction. Studies have shown that glucocorticoids like prednisolone can decrease bone formation, and this is typically associated with extended or high-dose systemic exposure.


Q: What are the general guidelines for children using prednisolone?

Official guidance stresses that the growth and development of infants and children on prolonged corticosteroid therapy should be carefully observed. Dosing for pediatric patients is often based on metrics like body weight or surface area to ensure appropriate levels.


Q: Why do some people experience trouble sleeping while taking prednisolone?

Insomnia and problems sleeping are officially listed as potential adverse reactions in the product labeling. These effects are related to the central nervous system and psychiatric changes that can sometimes occur while taking this type of medication.


Q: Are there specific vitamins or minerals that might be affected by prednisolone use?

Official information indicates that corticosteroids can affect calcium balance, notably by increasing its excretion from the body. Because of this, supplementation with calcium and vitamin D is frequently discussed for individuals on long-term glucocorticoid therapy.


Q: Does taking prednisolone affect blood sugar levels?

Yes, official safety information states that prednisolone can potentially raise blood sugar levels and reduce the effectiveness of insulin. This is why hyperglycemia (high blood sugar) is listed as a potential adverse reaction, and blood sugar monitoring is often required.


Q: How long does prednisolone stay in your system after the last dose?

Regulatory data on pharmacokinetics indicates that prednisolone is eliminated from the plasma with a half-life of approximately 2 to 4 hours following oral administration. This timeframe describes how quickly the concentration of the drug is reduced in the bloodstream.


Q: Why is it recommended to take prednisolone with food in some cases?

Official administration guidelines note that oral forms are frequently taken with or after food or milk. This condition is recommended to help mitigate gastrointestinal upset or irritation in the stomach and digestive tract.


Q: Can people with high blood pressure use prednisolone?

Official documents state that the use of prednisolone requires special caution and close monitoring in patients with pre-existing hypertension (high blood pressure). Elevation of blood pressure is a known potential effect of this class of corticosteroids.


Q: Is there a link between prednisolone and cataracts?

Yes, official safety documents indicate that the use of corticosteroids may produce posterior subcapsular cataracts. This potential side effect is typically associated with long-term systemic exposure to the medication.


Q: Can prednisolone be used for allergies or allergic reactions?

According to official uses, prednisolone is an recognized treatment for certain conditions, including severe allergic reactions or allergy-related disorders. Its potent anti-inflammatory properties help to manage the symptoms associated with these reactions.


Q: Is it common to feel jittery or restless after taking prednisolone?

Official safety information lists feelings of restlessness as a potential adverse reaction. Other related effects such as mood changes, agitation, and insomnia are also documented, as these medications can have effects on the central nervous system.


Q: What are some common short-term effects people experience when starting prednisolone?

Common effects that can occur early in treatment, according to safety documents, may include stomach upset, mood changes, problems sleeping (insomnia), and an increased appetite. These are generally related to the initial systemic activity of the drug.


Q: Does prednisolone interact with common pain relievers like ibuprofen?

Combining prednisolone with NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), such as ibuprofen, is noted in drug labels. Co-administration is associated with an increased risk of side effects in the gastrointestinal tract, including inflammation, bleeding, and ulceration.


Q: Is there a known interaction between prednisolone and alcohol?

While there is no direct chemical interaction specified in official labeling, official labeling indicates that caution should be exercised. Both alcohol and prednisolone can affect the immune system and cause stomach irritation, which may increase the risk of these side effects when used together.


Q: Is prednisolone used for asthma or chronic obstructive pulmonary disease (COPD)?

Prednisolone is officially recognized for the treatment of conditions like asthma, particularly for managing acute flare-ups or exacerbations. It is also used to manage acute exacerbations of COPD, utilizing its anti-inflammatory properties.


Q: What kind of monitoring is typically involved for people on long-term prednisolone?

For individuals on prolonged therapy, monitoring may include regular checks of blood pressure, intraocular pressure (eye pressure), and bone mineral density (BMD). Laboratory testing of glucose and electrolytes may also be included to watch for known effects.


Q: Are there certain foods that should be avoided while on prednisolone?

Official labeling specifically notes that certain non-drug products, such as natural licorice, can potentially potentiate (strengthen) corticosteroid effects and should be used cautiously. General food restrictions are typically not specified in the labeling.


Q: Does prednisolone have different names in other countries?

Prednisolone is the International Nonproprietary Name (INN) for the active substance. It is found in numerous formulations globally under various brand names. For example, in the US, some brand names include Orapred and Prelone, although brand names vary widely by region.


Q: Do older adults typically experience different side effects from prednisolone?

Official documents note that older adults may have an increased risk of certain adverse effects, such as hypertension (high blood pressure). They generally require close supervision due to the possibility that common effects may have more serious consequences.


Q: How does prednisolone interact with common vaccines?

Regulatory information indicates that live attenuated vaccines are contraindicated (must not be used) during immunosuppressive therapy. Corticosteroids, especially at higher doses, may reduce the immune response to all types of vaccines.


Q: What should a patient generally know about combining prednisolone with herbal supplements?

Information on combining prednisolone with most herbal remedies or supplements is generally limited in official documents. Caution is advised because these products are often not tested in the same way as prescription medicines, and there is a risk of unforeseen interactions.


Q: Can prednisolone affect energy levels or cause fatigue?

Official documentation lists unusual tiredness or weakness and loss of appetite as potential adverse reactions. These effects may sometimes be associated with complications like adrenal gland problems following cessation of the drug.


Q: What is the expected duration of prednisolone treatment for acute conditions?

For many acute or short-term conditions, the initial dose level is often maintained for a brief period, typically around 4 to 10 days. Following this, the dose is usually reduced gradually according to official administration guidelines.


Q: What kind of studies have been done on prednisolone in different ethnic populations?

Studies have investigated the pharmacokinetics (how the body handles the drug) and pharmacodynamics (how the drug affects the body) in relation to race and sex. This research suggests there may be differences in drug disposition and responsiveness across different ethnic populations.

Advertisements

How should Prednisolone - General Pharma be stored and disposed of?

How to Store and Dispose of Prednisolone

Storage of Prednisolone must adhere strictly to regulatory conditions to maintain its stability.

Prednisolone tablets are generally required to be stored at temperatures below 25 C or 30 C. The oral solution requires storage at Controlled Room Temperature (20 C to 25 C) in light-resistant containers and must not be refrigerated.


Official Storage and Handling Constraints

  • Temperature Restrictions: Avoid extremes; do not refrigerate the oral solution, and do not freeze the ophthalmic suspension.
  • Environmental Protection: All formulations require protection from light.
  • Child Safety: Prednisolone must be stored out of the sight and reach of children; the oral solution requires child-resistant packaging.

Disposal of unused or expired Prednisolone must be carried out according to local regulations; regulatory documents typically state no special requirements beyond local compliance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednisolone - General Pharma found in:

A-Z Index: